Winter R
Department of Obstetrics and Gynecology, University of Graz, Austria.
J Obstet Gynaecol Res. 1998 Dec;24(6):433-6. doi: 10.1111/j.1447-0756.1998.tb00120.x.
To evaluate the prognosis of patients with stage IA1 and IA2 microcarcinoma of the cervix according to the 1994 FIGO classification.
The histologic specimens of 494 patients who underwent conization for microcarcinoma of the cervix between 1958 and 1992 were reviewed and classified according to the 1994 FIGO system.
After a mean follow-up of 14 years (range, 1-35) 2 patients with stage IA1 tumors and 2 patients with stage IA2 tumors died of disease. Patients with early stromal invasion only accounted for 70% of patients with stage IA1 lesions. If these patients are excluded from stage IAI, the mortality rates for stage IA1 and IA2 did not differ significantly. Surgical radicality declined markedly during the study period.
Neither the 1985 nor the 1994 FIGO classification of microcarcinoma can be used as a guide to therapy. Conization only suffices for patients with early stromal invasion or a depth of invasion of 1-3 mm without lymph vascular space involvement. Additional pelvic lymphadenectomy can be considered for patients with stage IA1 lesions with lymph vascular space involvement. Removal of the tumor and pelvic lymphadenectomy is indicated for all patients with stage IA2 lesions, regardless of lymph vascular space involvement. Radical vaginal or radical abdominal hysterectomy represent overtreatment for patients with microcarcinomas because parametrial involvement in these patients has not been demonstrated.
根据1994年国际妇产科联盟(FIGO)分类评估IA1期和IA2期宫颈微癌患者的预后。
回顾性分析1958年至1992年间因宫颈微癌接受锥切术的494例患者的组织学标本,并根据1994年FIGO系统进行分类。
平均随访14年(范围1 - 35年)后,2例IA1期肿瘤患者和2例IA2期肿瘤患者死于该疾病。仅早期间质浸润的患者占IA1期病变患者的70%。如果将这些患者排除在IA1期之外,IA1期和IA2期的死亡率无显著差异。在研究期间,手术根治性明显下降。
1985年和1994年FIGO对微癌的分类均不能作为治疗指南。锥切术仅适用于早期间质浸润或浸润深度为1 - 3mm且无淋巴管间隙受累的患者。对于有淋巴管间隙受累的IA1期病变患者,可考虑行盆腔淋巴结清扫术。所有IA2期病变患者,无论是否有淋巴管间隙受累,均需行肿瘤切除及盆腔淋巴结清扫术。根治性阴道或根治性腹式子宫切除术对微癌患者属于过度治疗,因为这些患者未证实有宫旁组织受累。